🇺🇸 FDA
Patent

US 10151763

Treatment and differential diagnosis of Cushing's disease and ectopic Cushing's syndrome

granted A61PA61P5/38

Quick answer

US patent 10151763 (Treatment and differential diagnosis of Cushing's disease and ectopic Cushing's syndrome) held by Corcept Therapeutics Incorporated expires Mon Dec 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Corcept Therapeutics Incorporated
Grant date
Tue Dec 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61P, A61P5/38